Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1446194 BALA CYNWYD, PA

Position in TNXP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$406,711
-$56,609 QoQ
Shares Held
29,579
-0.3% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Derivatives in TNXP

reported options exposure · as of Mar 31, 2026
CallValue
$732,875
CallShares
53,300
PutValue
$1,032,625
PutShares
75,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. TNXP ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TNXP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $732,875 53,300
2026-03-31 $1,032,625 75,100
2026-03-31 $406,711 29,579
2025-12-31 $463,320 29,662
2025-12-31 $365,508 23,400
2025-12-31 $551,386 35,300
2025-09-30 $343,072 14,200
2025-09-30 $521,856 21,600
2025-09-30 $211,400 8,750
2025-06-30 $324,107 9,008